X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5672) 5672
Publication (349) 349
Newsletter (123) 123
Book Review (41) 41
Magazine Article (23) 23
Book Chapter (20) 20
Book / eBook (12) 12
Newspaper Article (12) 12
Government Document (11) 11
Conference Proceeding (5) 5
Dissertation (4) 4
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5104) 5104
neurofibromatosis 1 - complications (3579) 3579
female (3056) 3056
male (2929) 2929
adult (2043) 2043
neurofibromatosis (1900) 1900
child (1526) 1526
index medicus (1362) 1362
adolescent (1325) 1325
middle aged (1324) 1324
child, preschool (932) 932
neurofibromatosis 1 - pathology (813) 813
neurofibromatosis 1 - diagnosis (810) 810
clinical neurology (715) 715
surgery (712) 712
magnetic resonance imaging (668) 668
infant (583) 583
pediatrics (581) 581
neurofibromatosis type 1 (579) 579
neurofibromatosis 1 - genetics (541) 541
children (525) 525
aged (514) 514
tumors (469) 469
tomography, x-ray computed (454) 454
treatment outcome (387) 387
radiography (386) 386
diagnosis, differential (377) 377
diagnosis (359) 359
retrospective studies (352) 352
neurofibromatosis 1 (351) 351
neurofibromatosis 1 - surgery (335) 335
research (318) 318
care and treatment (314) 314
follow-up studies (312) 312
nf1 (308) 308
young adult (302) 302
oncology (299) 299
neurofibromatosis 1 - diagnostic imaging (274) 274
risk factors (258) 258
mutation (252) 252
genetics & heredity (248) 248
skin neoplasms - complications (235) 235
type-1 (233) 233
medicine & public health (227) 227
management (225) 225
neurofibromatosis 2 - complications (221) 221
neurofibromatoses - complications (217) 217
neurosciences (216) 216
disease (207) 207
neurofibromatosis type-1 (206) 206
case report (196) 196
dermatology (191) 191
genetic aspects (187) 187
complications and side effects (183) 183
prognosis (175) 175
ophthalmology (173) 173
neurofibromatosis 1 - physiopathology (172) 172
pathology (172) 172
gene (167) 167
infant, newborn (165) 165
cancer (164) 164
neurofibroma (161) 161
medicine, general & internal (159) 159
case studies (158) 158
orthopedics (158) 158
pregnancy (153) 153
animals (152) 152
medicine (151) 151
neoplasms (150) 150
health aspects (149) 149
brain neoplasms - complications (144) 144
pheochromocytoma - complications (144) 144
patients (142) 142
otorhinolaryngology (139) 139
neurofibromatosis 1 - therapy (138) 138
article (136) 136
recklinghausen's disease (136) 136
analysis (134) 134
congenital, hereditary, and neonatal diseases and abnormalities (134) 134
patient (134) 134
phenotype (134) 134
vonrecklinghausen neurofibromatosis (134) 134
neurology (132) 132
abridged index medicus (125) 125
gliomas (120) 120
neurilemmoma - complications (119) 119
neurofibromatosis 1 - epidemiology (119) 119
radiology, nuclear medicine & medical imaging (117) 117
mutations (116) 116
skin neoplasms - pathology (116) 116
immunohistochemistry (115) 115
pedigree (112) 112
neurilemmoma - pathology (111) 111
age factors (110) 110
nervous system diseases (109) 109
neurosurgery (108) 108
von recklinghausen's disease (108) 108
biopsy (106) 106
fatal outcome (105) 105
genetics (104) 104
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4705) 4705
French (358) 358
German (205) 205
Japanese (168) 168
Spanish (125) 125
Italian (70) 70
Russian (57) 57
Polish (45) 45
Portuguese (19) 19
Dutch (17) 17
Hungarian (15) 15
Czech (14) 14
Romanian (14) 14
Danish (10) 10
Korean (10) 10
Serbian (7) 7
Chinese (6) 6
Croatian (6) 6
Norwegian (6) 6
Hebrew (5) 5
Turkish (5) 5
Swedish (3) 3
Bulgarian (1) 1
Finnish (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2013, Volume 209, Issue 1, pp. 46.e1 - 46.e8
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 02/2016, Volume 74, Issue 2, pp. 231 - 231
There are a significant number of diseases and treatment considerations of considerable importance relating to the skin and renal systems. This emphasizes the... 
genetic | nephrology | dermatology | autoimmune | genodermatoses | inflammatory | nephrocutaneous | Uterine Neoplasms - therapy | Skin Diseases - genetics | Tuberous Sclerosis - complications | Beckwith-Wiedemann Syndrome - therapy | Fabry Disease - genetics | Humans | Genetic Diseases, Inborn - genetics | von Hippel-Lindau Disease - complications | Genetic Diseases, Inborn - therapy | Beckwith-Wiedemann Syndrome - genetics | Kidney Diseases - genetics | Nail-Patella Syndrome - therapy | Neurofibromatosis 1 - therapy | Neoplastic Syndromes, Hereditary | Beckwith-Wiedemann Syndrome - complications | Leiomyomatosis - complications | Leiomyomatosis - therapy | Birt-Hogg-Dube Syndrome - complications | Turner Syndrome - complications | Turner Syndrome - therapy | Neurofibromatosis 1 - genetics | Uterine Neoplasms - genetics | von Hippel-Lindau Disease - therapy | Hamartoma Syndrome, Multiple - genetics | Skin Neoplasms - therapy | Nail-Patella Syndrome - genetics | Fabry Disease - complications | von Hippel-Lindau Disease - genetics | Hamartoma Syndrome, Multiple - complications | Birt-Hogg-Dube Syndrome - genetics | Tuberous Sclerosis - genetics | Tuberous Sclerosis - therapy | Skin Neoplasms - complications | Birt-Hogg-Dube Syndrome - therapy | Hamartoma Syndrome, Multiple - therapy | Skin Neoplasms - genetics | Neurofibromatosis 1 - complications | Uterine Neoplasms - complications | Nail-Patella Syndrome - complications | Turner Syndrome - genetics | Fabry Disease - therapy | Mutation | Leiomyomatosis - genetics
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 12, pp. 1218 - 1224
Journal Article
Journal Article
World Journal of Surgical Oncology, ISSN 1477-7819, 08/2017, Volume 15, Issue 1, p. 160
Background: Neurofibromatosis type 1 (NF1) is an autosomally dominant inherited disorder characterized by multiple pigmented skin spots (cafE-au-lait spots)... 
SURGERY | NF1 | RECKLINGHAUSENS DISEASE | GENE | ONCOLOGY | MANIFESTATIONS | Adenocarcinoma - pathology | Jejunum - pathology | Humans | Tomography, X-Ray Computed - methods | Neurofibromatosis 1 - therapy | Duodenal Neoplasms - complications | Neurofibroma - pathology | Neoplasms, Multiple Primary - therapy | Laparoscopy - methods | Chemotherapy, Adjuvant - adverse effects | Contrast Media - administration & dosage | Skin Neoplasms - diagnosis | Endoscopy, Gastrointestinal - methods | Occult Blood | Rectal Neoplasms - pathology | Duodenum - diagnostic imaging | Duodenal Neoplasms - pathology | Digestive System Surgical Procedures - methods | Skin Neoplasms - therapy | Rectal Neoplasms - complications | Neurofibromatosis 1 - diagnosis | Lymphatic Metastasis | Withholding Treatment | Intestinal Neoplasms - pathology | Intestinal Neoplasms - therapy | Adenocarcinoma - diagnosis | Gastrointestinal Stromal Tumors - therapy | Adenocarcinoma - therapy | Neurofibromatosis 1 - complications | Neoplasms, Multiple Primary - complications | Intestinal Neoplasms - complications | Rectal Neoplasms - diagnosis | Prognosis | Intestine, Small - pathology | Neurofibroma - complications | Diarrhea - chemically induced | Gastrointestinal Stromal Tumors - diagnosis | Gastrointestinal Stromal Tumors - pathology | Female | Intestinal Neoplasms - diagnosis | Neurofibroma - diagnosis | Neoplasms, Multiple Primary - diagnosis | Skin Neoplasms - pathology | Jejunum - surgery | Duodenal Neoplasms - therapy | Duodenal Neoplasms - diagnosis | Neoplasms, Multiple Primary - pathology | Rectal Neoplasms - therapy | Adenocarcinoma - complications | Skin Neoplasms - complications | Neurofibroma - therapy | Neurofibromatosis 1 - pathology | Duodenum - surgery | Intestine, Small - surgery | Biopsy | Chemotherapy, Adjuvant - methods | Duodenum - pathology | Intestine, Small - diagnostic imaging | Gastrointestinal Stromal Tumors - complications | Aged | Neoplasm Staging | Jejunum - diagnostic imaging | Case studies | Complications and side effects | Care and treatment | Neurofibromatosis | Colorectal cancer | Diagnosis | Stomach cancer | Risk factors | Adenocarcinoma | Colorectal carcinoma | Nervous system | Small intestine | Lymph nodes | Metastases | Proteins | Endoscopes | Jejunum | Colonoscopy | Surgery | Spots | Population | Endoscopy | Colon | Digestive tract | CD34 antigen | Antigens | Lymphatic system | Risk groups | Duodenum | Histology | Laparoscopy | Recklinghausen's disease | Patients | Hereditary diseases | Abdomen | Nodules | Ostomy | Rectum | Skin | Mutation | Cancer | Tumors
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 05/2018, Volume 138, Issue 1, pp. 183 - 190
Immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) or its ligand (PD-L1) have been shown to be effective in treating patients with a variety... 
Tumor infiltrating lymphocytes | Programmed death-ligand 1 | Neurofibromatosis type 1 | Neurofibromatosis type 2 | Meningioma | Neurofibroma | Schwannoma | B7-H1 EXPRESSION | GLIOMA | CANCER | CLINICAL NEUROLOGY | INHIBITION | ONCOLOGY | GROWTH-FACTOR | VESTIBULAR SCHWANNOMAS | PD-L1 ANTIBODIES | CELL | TUMORIGENESIS | Neurofibromatosis 2 - complications | Central Nervous System Neoplasms - metabolism | Meningioma - metabolism | Humans | Middle Aged | Male | Meningioma - complications | Neurilemmoma - pathology | Antigens, CD - metabolism | Young Adult | Meningioma - pathology | B7-H1 Antigen - metabolism | Central Nervous System Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Neurilemmoma - metabolism | Adolescent | Neurofibromatosis 1 - complications | Neurilemmoma - complications | Adult | Female | Central Nervous System Neoplasms - complications | Child | Immunohistochemistry | Lymphocytes | Cell death | Immunotherapy | Neurofibromatosis | Formaldehyde | Cancer | Parkinson's disease | PD-1 protein | Neurodegenerative diseases | Tumor cells | CD8 antigen | Clinical trials | Neurofibromin 2 | CD3 antigen | Paraffin | Recklinghausen's disease | Immunity (cell-mediated) | Immune checkpoint | CD20 antigen | Ligands | Skin | Movement disorders | Apoptosis | Tumors | meningioma | tumor infiltrating lymphocytes | neurofibromatosis type 1 | neurofibromatosis type 2 | neurofibroma | programmed death-ligand 1 | schwannoma
Journal Article